カテゴリー： Market Monitor Global, 世界, 医療/バイオ

生物学的治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Biologic Therapeutic Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5715）

◆商品コード：MMG23JU5715
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：69
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Biologic Therapeutic Drug Market 調査レポートは次の情報を含め、グローバルにおけるの生物学的治療薬市場規模と予測を収録しています。・世界の生物学的治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の生物学的治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の生物学的治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル抗体」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

生物学的治療薬のグローバル主要企業は、Aurobindo Pharma Ltd.、 Concord Biotech、 GlaxoSmithKline Plc.、 H. Lundbeck A/S、 Novartis Global、 Retractable Technologies, Inc.、 Smith Medical、 AstraZeneca、 Pfizer Inc.、 Merck and Co. Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、生物学的治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の生物学的治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の生物学的治療薬市場：タイプ別市場シェア、2022年
・モノクローナル抗体、治療用タンパク質、ワクチン

世界の生物学的治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の生物学的治療薬市場：用途別市場シェア、2022年
・臨床医学、研究室、その他

世界の生物学的治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の生物学的治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における生物学的治療薬のグローバル売上、2018年-2023年
・主要企業における生物学的治療薬のグローバル売上シェア、2022年
・主要企業における生物学的治療薬のグローバル販売量、2018年-2023年
・主要企業における生物学的治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Aurobindo Pharma Ltd.、 Concord Biotech、 GlaxoSmithKline Plc.、 H. Lundbeck A/S、 Novartis Global、 Retractable Technologies, Inc.、 Smith Medical、 AstraZeneca、 Pfizer Inc.、 Merck and Co. Inc.

*************************************************************

・調査・分析レポートの概要
生物学的治療薬市場の定義
市場セグメント
世界の生物学的治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の生物学的治療薬市場規模
世界の生物学的治療薬市場規模：2022年 VS 2029年
世界の生物学的治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの生物学的治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の生物学的治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル抗体、治療用タンパク質、ワクチン
生物学的治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：臨床医学、研究室、その他
生物学的治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別生物学的治療薬市場規模 2022年と2029年
地域別生物学的治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Aurobindo Pharma Ltd.、 Concord Biotech、 GlaxoSmithKline Plc.、 H. Lundbeck A/S、 Novartis Global、 Retractable Technologies, Inc.、 Smith Medical、 AstraZeneca、 Pfizer Inc.、 Merck and Co. Inc.
...

Biologic Therapeutic Drug are used for treatment of numerous diseases and conditions, and are the most advanced therapies.
This report aims to provide a comprehensive presentation of the global market for Biologic Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutic Drug. This report contains market size and forecasts of Biologic Therapeutic Drug in global, including the following market information:
Global Biologic Therapeutic Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biologic Therapeutic Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biologic Therapeutic Drug include Aurobindo Pharma Ltd., Concord Biotech, GlaxoSmithKline Plc., H. Lundbeck A/S, Novartis Global, Retractable Technologies, Inc., Smith Medical, AstraZeneca and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologic Therapeutic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Therapeutic Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biologic Therapeutic Drug Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Global Biologic Therapeutic Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biologic Therapeutic Drug Market Segment Percentages, by Application, 2022 (%)
Clinical Medicine
Laboratory
Others
Global Biologic Therapeutic Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biologic Therapeutic Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologic Therapeutic Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biologic Therapeutic Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aurobindo Pharma Ltd.
Concord Biotech
GlaxoSmithKline Plc.
H. Lundbeck A/S
Novartis Global
Retractable Technologies, Inc.
Smith Medical
AstraZeneca
Pfizer Inc.
Merck and Co. Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologic Therapeutic Drug, market overview.
Chapter 2: Global Biologic Therapeutic Drug market size in revenue.
Chapter 3: Detailed analysis of Biologic Therapeutic Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologic Therapeutic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Biologic Therapeutic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologic Therapeutic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologic Therapeutic Drug Overall Market Size
2.1 Global Biologic Therapeutic Drug Market Size: 2022 VS 2029
2.2 Global Biologic Therapeutic Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biologic Therapeutic Drug Players in Global Market
3.2 Top Global Biologic Therapeutic Drug Companies Ranked by Revenue
3.3 Global Biologic Therapeutic Drug Revenue by Companies
3.4 Top 3 and Top 5 Biologic Therapeutic Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biologic Therapeutic Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologic Therapeutic Drug Players in Global Market
3.6.1 List of Global Tier 1 Biologic Therapeutic Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Biologic Therapeutic Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Biologic Therapeutic Drug Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Proteins
4.1.4 Vaccines
4.2 By Type – Global Biologic Therapeutic Drug Revenue & Forecasts
4.2.1 By Type – Global Biologic Therapeutic Drug Revenue, 2018-2023
4.2.2 By Type – Global Biologic Therapeutic Drug Revenue, 2024-2029
4.2.3 By Type – Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biologic Therapeutic Drug Market Size, 2022 & 2029
5.1.2 Clinical Medicine
5.1.3 Laboratory
5.1.4 Others
5.2 By Application – Global Biologic Therapeutic Drug Revenue & Forecasts
5.2.1 By Application – Global Biologic Therapeutic Drug Revenue, 2018-2023
5.2.2 By Application – Global Biologic Therapeutic Drug Revenue, 2024-2029
5.2.3 By Application – Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Biologic Therapeutic Drug Market Size, 2022 & 2029
6.2 By Region – Global Biologic Therapeutic Drug Revenue & Forecasts
6.2.1 By Region – Global Biologic Therapeutic Drug Revenue, 2018-2023
6.2.2 By Region – Global Biologic Therapeutic Drug Revenue, 2024-2029
6.2.3 By Region – Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Biologic Therapeutic Drug Revenue, 2018-2029
6.3.2 US Biologic Therapeutic Drug Market Size, 2018-2029
6.3.3 Canada Biologic Therapeutic Drug Market Size, 2018-2029
6.3.4 Mexico Biologic Therapeutic Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Biologic Therapeutic Drug Revenue, 2018-2029
6.4.2 Germany Biologic Therapeutic Drug Market Size, 2018-2029
6.4.3 France Biologic Therapeutic Drug Market Size, 2018-2029
6.4.4 U.K. Biologic Therapeutic Drug Market Size, 2018-2029
6.4.5 Italy Biologic Therapeutic Drug Market Size, 2018-2029
6.4.6 Russia Biologic Therapeutic Drug Market Size, 2018-2029
6.4.7 Nordic Countries Biologic Therapeutic Drug Market Size, 2018-2029
6.4.8 Benelux Biologic Therapeutic Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Biologic Therapeutic Drug Revenue, 2018-2029
6.5.2 China Biologic Therapeutic Drug Market Size, 2018-2029
6.5.3 Japan Biologic Therapeutic Drug Market Size, 2018-2029
6.5.4 South Korea Biologic Therapeutic Drug Market Size, 2018-2029
6.5.5 Southeast Asia Biologic Therapeutic Drug Market Size, 2018-2029
6.5.6 India Biologic Therapeutic Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Biologic Therapeutic Drug Revenue, 2018-2029
6.6.2 Brazil Biologic Therapeutic Drug Market Size, 2018-2029
6.6.3 Argentina Biologic Therapeutic Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Biologic Therapeutic Drug Revenue, 2018-2029
6.7.2 Turkey Biologic Therapeutic Drug Market Size, 2018-2029
6.7.3 Israel Biologic Therapeutic Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Biologic Therapeutic Drug Market Size, 2018-2029
6.7.5 UAE Biologic Therapeutic Drug Market Size, 2018-2029
7 Biologic Therapeutic Drug Companies Profiles
7.1 Aurobindo Pharma Ltd.
7.1.1 Aurobindo Pharma Ltd. Company Summary
7.1.2 Aurobindo Pharma Ltd. Business Overview
7.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Major Product Offerings
7.1.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.1.5 Aurobindo Pharma Ltd. Key News & Latest Developments
7.2 Concord Biotech
7.2.1 Concord Biotech Company Summary
7.2.2 Concord Biotech Business Overview
7.2.3 Concord Biotech Biologic Therapeutic Drug Major Product Offerings
7.2.4 Concord Biotech Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.2.5 Concord Biotech Key News & Latest Developments
7.3 GlaxoSmithKline Plc.
7.3.1 GlaxoSmithKline Plc. Company Summary
7.3.2 GlaxoSmithKline Plc. Business Overview
7.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Major Product Offerings
7.3.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.4 H. Lundbeck A/S
7.4.1 H. Lundbeck A/S Company Summary
7.4.2 H. Lundbeck A/S Business Overview
7.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Major Product Offerings
7.4.4 H. Lundbeck A/S Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.4.5 H. Lundbeck A/S Key News & Latest Developments
7.5 Novartis Global
7.5.1 Novartis Global Company Summary
7.5.2 Novartis Global Business Overview
7.5.3 Novartis Global Biologic Therapeutic Drug Major Product Offerings
7.5.4 Novartis Global Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.5.5 Novartis Global Key News & Latest Developments
7.6 Retractable Technologies, Inc.
7.6.1 Retractable Technologies, Inc. Company Summary
7.6.2 Retractable Technologies, Inc. Business Overview
7.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Major Product Offerings
7.6.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.6.5 Retractable Technologies, Inc. Key News & Latest Developments
7.7 Smith Medical
7.7.1 Smith Medical Company Summary
7.7.2 Smith Medical Business Overview
7.7.3 Smith Medical Biologic Therapeutic Drug Major Product Offerings
7.7.4 Smith Medical Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.7.5 Smith Medical Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Biologic Therapeutic Drug Major Product Offerings
7.8.4 AstraZeneca Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Biologic Therapeutic Drug Major Product Offerings
7.9.4 Pfizer Inc. Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 Merck and Co. Inc.
7.10.1 Merck and Co. Inc. Company Summary
7.10.2 Merck and Co. Inc. Business Overview
7.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Major Product Offerings
7.10.4 Merck and Co. Inc. Biologic Therapeutic Drug Revenue in Global Market (2018-2023)
7.10.5 Merck and Co. Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Biologic Therapeutic Drug Market Opportunities & Trends in Global Market
Table 2. Biologic Therapeutic Drug Market Drivers in Global Market
Table 3. Biologic Therapeutic Drug Market Restraints in Global Market
Table 4. Key Players of Biologic Therapeutic Drug in Global Market
Table 5. Top Biologic Therapeutic Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biologic Therapeutic Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biologic Therapeutic Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biologic Therapeutic Drug Product Type
Table 9. List of Global Tier 1 Biologic Therapeutic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologic Therapeutic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Biologic Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biologic Therapeutic Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biologic Therapeutic Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Biologic Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biologic Therapeutic Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biologic Therapeutic Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Biologic Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biologic Therapeutic Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biologic Therapeutic Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biologic Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biologic Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biologic Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biologic Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biologic Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 30. Aurobindo Pharma Ltd. Company Summary
Table 31. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Offerings
Table 32. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Aurobindo Pharma Ltd. Key News & Latest Developments
Table 34. Concord Biotech Company Summary
Table 35. Concord Biotech Biologic Therapeutic Drug Product Offerings
Table 36. Concord Biotech Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Concord Biotech Key News & Latest Developments
Table 38. GlaxoSmithKline Plc. Company Summary
Table 39. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Offerings
Table 40. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Plc. Key News & Latest Developments
Table 42. H. Lundbeck A/S Company Summary
Table 43. H. Lundbeck A/S Biologic Therapeutic Drug Product Offerings
Table 44. H. Lundbeck A/S Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 45. H. Lundbeck A/S Key News & Latest Developments
Table 46. Novartis Global Company Summary
Table 47. Novartis Global Biologic Therapeutic Drug Product Offerings
Table 48. Novartis Global Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Global Key News & Latest Developments
Table 50. Retractable Technologies, Inc. Company Summary
Table 51. Retractable Technologies, Inc. Biologic Therapeutic Drug Product Offerings
Table 52. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Retractable Technologies, Inc. Key News & Latest Developments
Table 54. Smith Medical Company Summary
Table 55. Smith Medical Biologic Therapeutic Drug Product Offerings
Table 56. Smith Medical Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Smith Medical Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Biologic Therapeutic Drug Product Offerings
Table 60. AstraZeneca Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. Biologic Therapeutic Drug Product Offerings
Table 64. Pfizer Inc. Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Inc. Key News & Latest Developments
Table 66. Merck and Co. Inc. Company Summary
Table 67. Merck and Co. Inc. Biologic Therapeutic Drug Product Offerings
Table 68. Merck and Co. Inc. Biologic Therapeutic Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Merck and Co. Inc. Key News & Latest Developments
List of Figures
Figure 1. Biologic Therapeutic Drug Segment by Type in 2022
Figure 2. Biologic Therapeutic Drug Segment by Application in 2022
Figure 3. Global Biologic Therapeutic Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biologic Therapeutic Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biologic Therapeutic Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biologic Therapeutic Drug Revenue in 2022
Figure 8. By Type - Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biologic Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biologic Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 16. US Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 20. Germany Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 28. China Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biologic Therapeutic Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biologic Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Concord Biotech Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. H. Lundbeck A/S Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Global Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Smith Medical Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Inc. Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck and Co. Inc. Biologic Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生物学的治療薬の世界市場見通し2023年-2029年(Biologic Therapeutic Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

生物学的治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp